Login  /  Register  | 3 premium articles left before you must register.

Amarin shares lower on speculation

Published September 12. 2012 4:00AM

The shares of Amarin Corp. plc, which has research-and-development headquarters in Groton, fell sharply Tuesday after the company disclosed that regulators have not yet decided whether to grant the maximum five-year protection from generic competition for its heart drug Vascepa.

Drugs like Vascepa that are designated as new chemical entities usually enjoy a five-year period of protection, so the lack of quick action by the U.S. Food and Drug Administration led to speculation that regulators might opt for three-year exclusivity.

The stock finished the day down about 6 percent, and analysts predicted more volatility until the FDA ruling is made public.

News by Town

Most Recent Poll
Harvard has received some unwelcome attention recently over a cheating scandal potentially involving at least 125 students. How common do you think cheating is on American campuses?
If it's happening at Harvard, it's happening everywhere.
Some students will always cheat but I don't think it's a widespread problem.
This is a huge problem and it's society's fault for emphasizing the grade at the expense of an enriching learning environment.
I'm a student and I cheat all the time. It's part of the college experience.
Number of votes: 368

No current items found